FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294044351> ?p ?o ?g. }

• W4294044351 endingPage "e0265998" @default.
• W4294044351 startingPage "e0265998" @default.
• W4294044351 abstract "Background We investigated differences in risk of stroke, with all-cause mortality as a competing risk, in people newly diagnosed with atrial fibrillation (AF) who were commenced on either direct oral anticoagulants (DOACs) or warfarin treatment. Methods and results We conducted a retrospective cohort study of the Oxford Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) database (a network of 500 English general practices). We compared long term exposure to DOAC (n = 5,168) and warfarin (n = 7,451) in new cases of AF not previously treated with oral anticoagulants. Analyses included: survival analysis, estimating cause specific hazard ratios (CSHR), Fine-Gray analysis for factors affecting cumulative incidence of events occurring over time and a cumulative risk regression with time varying effects.We found no difference in CSHR between stroke 1.08 (0.72–1.63, p = 0.69) and all-cause mortality 0.93 (0.81–1.08, p = 0.37), or between the anticoagulant groups. Fine-Gray analysis produced similar results 1.07 (0.71–1.6 p = 0.75) for stroke and 0.93 (0.8–1.07, p = 0.3) mortality. The cumulative risk of mortality with DOAC was significantly elevated in early follow-up (67 days), with cumulative risk decreasing until 1,537 days and all-cause mortality risk significantly decreased coefficient estimate:: -0.23 (-0.38–0.01, p = 0.001); which persisted over seven years of follow-up. Conclusions In this large, contemporary, real world primary care study with longer follow-up, we found no overall difference in the hazard of stroke between warfarin and DOAC treatment for AF. However, there was a significant time-varying effect between anti-coagulant regimen on all-cause mortality, with DOACs showing better survival. This is a key methodological observation for future follow-up studies, and reassuring for patients and health care professionals for longer duration of therapy" @default.
• W4294044351 created "2022-09-01" @default.
• W4294044351 creator A5000903907 @default.
• W4294044351 creator A5008167189 @default.
• W4294044351 creator A5042402378 @default.
• W4294044351 creator A5052532012 @default.
• W4294044351 creator A5065866497 @default.
• W4294044351 creator A5066377578 @default.
• W4294044351 creator A5070885678 @default.
• W4294044351 creator A5071204960 @default.
• W4294044351 creator A5084241436 @default.
• W4294044351 date "2022-09-01" @default.
• W4294044351 modified "2023-10-17" @default.
• W4294044351 title "Long term follow up of direct oral anticoagulants and warfarin therapy on stroke, with all-cause mortality as a competing risk, in people with atrial fibrillation: Sentinel network database study" @default.
• W4294044351 cites W1486552319 @default.
• W4294044351 cites W1782736155 @default.
• W4294044351 cites W1841486778 @default.
• W4294044351 cites W1969926175 @default.
• W4294044351 cites W2020152925 @default.
• W4294044351 cites W2023143117 @default.
• W4294044351 cites W2041055738 @default.
• W4294044351 cites W2050856345 @default.
• W4294044351 cites W2067443499 @default.
• W4294044351 cites W2103210722 @default.
• W4294044351 cites W2121504370 @default.
• W4294044351 cites W2125348945 @default.
• W4294044351 cites W2132633479 @default.
• W4294044351 cites W2159897547 @default.
• W4294044351 cites W2163278718 @default.
• W4294044351 cites W2517057643 @default.
• W4294044351 cites W2588060701 @default.
• W4294044351 cites W2593968870 @default.
• W4294044351 cites W2621026111 @default.
• W4294044351 cites W2738554408 @default.
• W4294044351 cites W2752023293 @default.
• W4294044351 cites W2754160328 @default.
• W4294044351 cites W2757025413 @default.
• W4294044351 cites W2769275060 @default.
• W4294044351 cites W2781836119 @default.
• W4294044351 cites W2788040427 @default.
• W4294044351 cites W2792857103 @default.
• W4294044351 cites W2795146524 @default.
• W4294044351 cites W2798896984 @default.
• W4294044351 cites W2799855806 @default.
• W4294044351 cites W2806294480 @default.
• W4294044351 cites W2810340659 @default.
• W4294044351 cites W2888686134 @default.
• W4294044351 cites W2889540815 @default.
• W4294044351 cites W2892188073 @default.
• W4294044351 cites W2908455207 @default.
• W4294044351 cites W2948648533 @default.
• W4294044351 cites W2969459603 @default.
• W4294044351 cites W2987142613 @default.
• W4294044351 cites W3000279845 @default.
• W4294044351 cites W3013323180 @default.
• W4294044351 cites W3030533492 @default.
• W4294044351 cites W2345271950 @default.
• W4294044351 cites W4211200033 @default.
• W4294044351 doi "https://doi.org/10.1371/journal.pone.0265998" @default.
• W4294044351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36048754" @default.
• W4294044351 hasPublicationYear "2022" @default.
• W4294044351 type Work @default.
• W4294044351 citedByCount "0" @default.
• W4294044351 crossrefType "journal-article" @default.
• W4294044351 hasAuthorship W4294044351A5000903907 @default.
• W4294044351 hasAuthorship W4294044351A5008167189 @default.
• W4294044351 hasAuthorship W4294044351A5042402378 @default.
• W4294044351 hasAuthorship W4294044351A5052532012 @default.
• W4294044351 hasAuthorship W4294044351A5065866497 @default.
• W4294044351 hasAuthorship W4294044351A5066377578 @default.
• W4294044351 hasAuthorship W4294044351A5070885678 @default.
• W4294044351 hasAuthorship W4294044351A5071204960 @default.
• W4294044351 hasAuthorship W4294044351A5084241436 @default.
• W4294044351 hasBestOaLocation W42940443511 @default.
• W4294044351 hasConcept C120665830 @default.
• W4294044351 hasConcept C121332964 @default.
• W4294044351 hasConcept C126322002 @default.
• W4294044351 hasConcept C127413603 @default.
• W4294044351 hasConcept C167135981 @default.
• W4294044351 hasConcept C187212893 @default.
• W4294044351 hasConcept C201903717 @default.
• W4294044351 hasConcept C207103383 @default.
• W4294044351 hasConcept C2776301958 @default.
• W4294044351 hasConcept C2779161974 @default.
• W4294044351 hasConcept C2780645631 @default.
• W4294044351 hasConcept C44249647 @default.
• W4294044351 hasConcept C50382708 @default.
• W4294044351 hasConcept C61511704 @default.
• W4294044351 hasConcept C71924100 @default.
• W4294044351 hasConcept C72563966 @default.
• W4294044351 hasConcept C78519656 @default.
• W4294044351 hasConcept C88879693 @default.
• W4294044351 hasConceptScore W4294044351C120665830 @default.
• W4294044351 hasConceptScore W4294044351C121332964 @default.
• W4294044351 hasConceptScore W4294044351C126322002 @default.
• W4294044351 hasConceptScore W4294044351C127413603 @default.
• W4294044351 hasConceptScore W4294044351C167135981 @default.
• W4294044351 hasConceptScore W4294044351C187212893 @default.

• next